Literature DB >> 30923049

Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations.

Ami B Patel1, Erin M Pettijohn2, Sameem M Abedin3, Evan Raps4, Michael W Deininger1.   

Abstract

Entities:  

Year:  2019        PMID： 30923049      PMCID： PMC6457233          DOI： 10.1182/bloodadvances.2019032300

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  14 in total

Review 1.  GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation.

Authors:  Burkhard Becher; Sonia Tugues; Melanie Greter
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

2.  RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.

Authors:  Clara Ricci; Elisa Fermo; Stefania Corti; Mauro Molteni; Alessio Faricciotti; Agostino Cortelezzi; Giorgio Lambertenghi Deliliers; Miloslav Beran; Francesco Onida
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

Review 3.  How I treat chronic myelomonocytic leukemia.

Authors:  Eric Solary; Raphael Itzykson
Journal:  Blood       Date:  2017-06-01       Impact factor: 22.113

4.  Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome.

Authors:  J R Novotny; H Müller-Beissenhirtz; S Herget-Rosenthal; A Kribben; U Dührsen
Journal:  Eur J Haematol       Date:  2005-06       Impact factor: 2.997

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

7.  A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML.

Authors:  Charlotte Lacronique-Gazaille; Marie-Pierre Chaury; Alexandre Le Guyader; Jean-Luc Faucher; Dominique Bordessoule; Jean Feuillard
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

8.  Urgent Coronary Artery Bypass Surgery in a Patient with Postinfarction Angina and Active Myelomonocytic Leukaemia.

Authors:  Samuel Anthony Galea; Joseph Galea
Journal:  Case Rep Oncol       Date:  2016-11-18

9.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

10.  Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance.

Authors:  M M Patnaik; M F Zahid; T L Lasho; C Finke; R L Ketterling; N Gangat; K D Robertson; C A Hanson; A Tefferi
Journal:  Blood Cancer J       Date:  2016-09-23       Impact factor: 11.037
View more
  3 in total

1.  Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic.

Authors:  Mrinal M Patnaik; Terra Lasho; Eric Padron; Kristen McCullough; Aref Al-Kali; Ayalew Tefferi; Amer M Zeidan; Naseema Gangat; Michael Savona; David P Steensma; Eric Solary
Journal:  Am J Hematol       Date:  2020-05-22       Impact factor: 10.047

2.  Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction.

Authors:  Megan Melody; Emily Butts; David Menke; Kevin Landolfo; Keith Oken; Taimur Sher; Sharad Khurana
Journal:  Leuk Res Rep       Date:  2020-11-04

3.  Post-operative hyperleukocytosis and leukostasis as the initial presentation of chronic myelomonocytic leukemia: A case report and review of literature.

Authors:  Sumit Gaur; Alexander Philipovskiy; Attilio Orazi
Journal:  Leuk Res Rep       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.